Reducing tobacco addiction through tobacco product regulation

Tobacco product regulation has the potential to help reduce tobacco attributable disease by reducing the toxicity of these products and by reducing the prevalence of tobacco use and addiction

Saved in:
Bibliographic Details
Published inTobacco control Vol. 13; no. 2; pp. 132 - 135
Main Authors Henningfield, J E, Benowitz, N L, Connolly, G N, Davis, R M, Gray, N, Myers, M L, Zeller, M
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group Ltd 01.06.2004
BMJ Publishing Group LTD
BMJ Group
Subjects
addiction
Addictions
Cigarettes
Design
Disease
FCTC
FDA
Federal regulation
Federal Trade Commission
Food and Drug Administration
Framework Convention on Tobacco Control
FTC
Ganglionic Stimulants - administration & dosage
harm reduction
Humans
ingredient
International Organization for Standardization
ISO
Liability
Litigation
Lungs
Mortality
Nicotine
Nicotine - administration & dosage
Product design
Public health
Public Health - legislation & jurisprudence
regulation
Smoking
Surveillance
Tobacco
Tobacco industry
Tobacco Industry - legislation & jurisprudence
Tobacco Use Disorder - prevention & control
Toxicity
United States
United States Food and Drug Administration
United States
Online AccessGet full text

Cover

More Information
Summary:Tobacco product regulation has the potential to help reduce tobacco attributable disease by reducing the toxicity of these products and by reducing the prevalence of tobacco use and addiction
Bibliography:local:0130132
Correspondence to:
 Jack E Henningfield PhD
 Pinney Associates, Inc, 4800 Montgomery Lane, Suite 1000, Bethesda, MD 20814, USA; jhenning@pinneyassociates.com
istex:05E6EA2BDB0CD20A2FC00CE74C645C0A3147150D
ark:/67375/NVC-2XKDXCWZ-X
href:tobaccocontrol-13-132.pdf
PMID:15175528
ISSN:0964-4563
1468-3318
DOI:10.1136/tc.2003.006890